DU5-16547-90858
1 vaccination
3 coded responses
3 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 275 / NC
- Registered
- 2021-05-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-06
Dose 1 — Moderna
-
2021-05-10
Registered in v-safe
-
2021-05-10
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Night sweats — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: Night sweats, back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — day 7, dose 1MedDRA: Blood glucose decreased — Feeling: Fair · Fatigue or tirednessFree text: Low blood sugarMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-06 | Moderna |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness
Systemic reaction (other): Night sweats, back pain
Release 8 — day 7, dose 1
Systemic reaction (other): Low blood sugar
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Blood glucose decreased | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release